Related Experiment Videos
[Is regression of coronary sclerosis possible?]
1Departement für Innere Medizin, Universitätsspital Zürich.
Insights
Aggressive lipid-lowering therapy and lifestyle changes can slow or reverse coronary artery lesions. These interventions also reduce clinical events, while certain calcium blockers prevent new stenoses.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Preventive Cardiology
Context:
- Coronary artery disease (CAD) progression and regression are key indicators of cardiovascular health.
- Sequential coronary arteriography provides objective measures of lesion changes.
- Lipid management and lifestyle modifications are central to CAD treatment strategies.
Purpose:
- To evaluate the impact of aggressive lipid-lowering therapy and lifestyle changes on coronary artery lesions.
- To determine the relationship between achieved cholesterol and LDL cholesterol levels and lesion modification.
- To assess the effect of specific calcium channel blockers (nifedipine, nicardipine) on stenosis development.
Summary:
- Randomized studies demonstrate that aggressive lipid-lowering therapy and lifestyle changes can reduce the progression and induce modest regression of coronary artery lesions.
- The degree of lesion change is directly related to the achieved levels of cholesterol and low-density lipoprotein (LDL) cholesterol.
- Three studies confirmed that lipid-lowering interventions not only improve arteriographic lesions but also decrease clinical events.
- Calcium blockers like nifedipine and nicardipine do not affect lesion progression or regression but reduce the formation of new coronary stenoses.
Impact:
- Aggressive lipid management and lifestyle interventions are effective in modifying coronary atherosclerosis.
- Achieving lower cholesterol and LDL cholesterol targets is crucial for regression of coronary lesions.
- These findings support the use of lipid-lowering therapies to reduce both arteriographic disease burden and clinical cardiovascular events.
- Specific calcium channel blockers may play a role in preventing the development of new coronary artery blockages.
Abstract:
Randomized studies with sequential coronary arteriographies have clearly documented that aggressive lipid-lowering therapy and change in life style can reduce progression and produce a modest regression of coronary artery lesions. The changes in the extent of a stenosis are determined by the level of cholesterol and LDL cholesterol achieved during treatment. Three of the randomized studies have shown that the lipid-lowering intervention has not only a beneficial influence on the coronary arteriographic lesions, but the number of clinical events is reduced as well. The calcium blockers nifedipine and nicardipine do not influence progression and regression but reduce the de novo appearance of coronary stenoses, either expressed as number of lesions per patient or as percentage of patients with new stenoses.